Rebus Holdings, Inc. (RBSH)
RBSH Stock Price Chart
Explore Rebus Holdings, Inc. interactive price chart. Choose custom timeframes to analyze RBSH price movements and trends.
RBSH Company Profile
Discover essential business fundamentals and corporate details for Rebus Holdings, Inc. (RBSH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Nov 2009
Employees
1.00
Website
https://www.rebus-corp.comCEO
Raul Silvestre
Description
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
RBSH Financial Timeline
Browse a chronological timeline of Rebus Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2023
EPS came in at $0.00 .
Earnings released on 31 Mar 2023
EPS came in at -$0.02 .
Earnings released on 31 Dec 2022
EPS came in at $0.05 .
Earnings released on 30 Sept 2022
EPS came in at $0.00 .
Earnings released on 11 Aug 2022
EPS came in at -$0.04 .
Earnings released on 13 May 2022
EPS came in at -$0.02 .
Earnings released on 31 Dec 2021
EPS came in at $0.00 .
Stock split effective on 12 Oct 2021
Shares were split 1 : 75 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2021
EPS came in at $0.16 .
Earnings released on 30 Jun 2021
EPS came in at $0.45 .
Earnings released on 31 Mar 2021
EPS came in at -$3.64 .
Earnings released on 31 Dec 2020
EPS came in at -$1.15 .
Earnings released on 30 Sept 2020
EPS came in at $0.29 .
RBSH Stock Performance
Access detailed RBSH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.